Author:
Dierssen-Sotos Trinidad,Gómez-Acebo Inés,de Pedro María,Pérez-Gómez Beatriz,Servitja Sonia,Moreno Víctor,Amiano Pilar,Fernandez-Villa Tania,Barricarte Aurelio,Tardon Adonina,Diaz-Santos Marian,Peiro-Perez Rosana,Marcos-Gragera Rafael,Lope Virginia,Gracia-Lavedan Esther,Alonso M. Henar,Michelena-Echeveste Maria Jesus,Garcia-Palomo Andrés,Guevara Marcela,Castaño-Vinyals Gemma,Aragonés Nuria,Kogevinas Manolis,Pollán Marina,Llorca Javier
Funder
Instituto de Salud Carlos III
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference45 articles.
1. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999;18(55):7908–16.
2. Harris RE, Alshafie GA, Seibert K. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res. 2000;20(8):2101–3.
3. Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA. Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer. 2000;83(1):112–20.
4. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A. Women’s Health Initiative. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women’s Health Initiative. Cancer Res. 2003;63(18):6096–101.
5. Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst. 2005;97(11):805–12.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献